Evidence map›Paper›PMID 21047140›Full record

ReviewMolecular pharmaceutics2011

The art of engineering viral nanoparticles.

Jonathan K Pokorski, Nicole F Steinmetz

Abstract readReview
In one paragraph

Review in Molecular pharmaceutics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed.

  1. Review
  2. Article
  3. Metallic nanoparticles: a promising novel therapeutic tool against antimicrobial resistance and spread of superbugs.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2025
    Review
  4. Review
  5. Article
  6. Recent advancements in single dose slow-release devices for prophylactic vaccines.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2023
    Review
  7. Article
  8. Article
  9. Bioconjugation Strategies for Tobacco Mild Green Mosaic Virus.Chembiochem : a European journal of chemical biology · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Plant Virus Nanoparticles for Anti-cancer Therapy.Frontiers in bioengineering and biotechnology · 2021
    Review
  17. Article
  18. Article
  19. Review
  20. Self-assembled Viral Nanoparticles as Targeted Anticancer Vehicles.Biotechnology and bioprocess engineering : BBE · 2021
    Review

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jonathan K PokorskiDepartment of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California 92037, USA.
Nicole F Steinmetz

Funding

Viral nanoparticles as platforms for the design of novel targeted therapeuticsR00EB009105 · NIBIB · CASE WESTERN RESERVE UNIVERSITY · PI STEINMETZ, NICOLE FRANZISKA · 2010 to 2012
$728k
Development of Protein-Displaying Peptide Hydrogels for Tissue EngineeringR00EB011530 · NIBIB · CASE WESTERN RESERVE UNIVERSITY · PI POKORSKI, JONATHAN KYLE · 2012 to 2014
$716k
Development of Protein-Displaying Peptide Hydrogels for Tissue EngineeringK99EB011530 · NIBIB · SCRIPPS RESEARCH INSTITUTE, THE · PI POKORSKI, JONATHAN KYLE · 2010 to 2011
$177k
Viral nanoparticles as platforms for the design of novel targeted therapeuticsK99EB009105 · NIBIB · SCRIPPS RESEARCH INSTITUTE, THE · PI STEINMETZ, NICOLE FRANZISKA · 2009 to 2010
$97k
NIBIB NIH HHS K99 EB009105NIBIB NIH HHS K99 EB011530NIBIB NIH HHS R00 EB009105NIBIB NIH HHS R00 EB011530
6 · The paper itself

Abstract

Viral nanotechnology is an emerging and highly interdisciplinary field in which viral nanoparticles (VNPs) are applied in diverse areas such as electronics, energy and next-generation medical devices. VNPs have been developed as candidates for novel materials, and are often described as "programmable" because they can be modified and functionalized using a number of techniques. In this review, we discuss the concepts and methods that allow VNPs to be engineered, including (i) bioconjugation chemistries, (ii) encapsulation techniques, (iii) mineralization strategies, and (iv) film and hydrogel development. With all these techniques in hand, the potential applications of VNPs are limited only by the imagination.

Indexed as

NanoparticlesNanotechnologyTissue EngineeringViruses

Identifiers

PMID21047140
PMCPMC3156490

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.